Arthur Mines
Family Medicine · Milwaukee, WINPI 1851438584
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 358 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,335 and has fallen 85.3% since, to $343 in 2025. Among family medicine clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 358 payments — averaging $16.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- AstraZeneca$846
- Pfizer$653
- AbbVie$598
- Boehringer Ingelheim$492
- Gilead$480
- plus $2K from 25 others
What the payments were for
- Food & beverage$5,93798%
- Education$1072%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 100 | $1,296 |
| AstraZeneca | 28 | $846 |
| Pfizer | 43 | $653 |
| AbbVie(2 entities) | 52 | $598 |
| Boehringer Ingelheim | 28 | $492 |
| Gilead | 11 | $480 |
| Merck | 16 | $273 |
| Novo Nordisk | 10 | $167 |
| Novartis | 10 | $155 |
| GSK | 8 | $138 |
| Ironwood Pharmaceuticals, Inc | 8 | $129 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Scilex Pharmaceuticals Inc. | 6 | $112 |
| Astellas Pharma US Inc | 2 | $92 |
| Nestle Healthcare Nutrition Inc. | 5 | $91 |
| Sanofi Pasteur Inc. | 4 | $60 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $46 |
| Sanofi-aventis U.S. LLC | 3 | $44 |
| Agile Therapeutics, Inc. | 2 | $36 |
| Aimmune Therapeutics, Inc. | 2 | $35 |
| Ardelyx, Inc. | 1 | $15 |
| Shionogi Inc | 1 | $14 |
| Lilly USA, LLC | 1 | $13 |
| Dexcom, Inc. | 1 | $13 |
| Sobi, Inc | 1 | $13 |
| Paratek Pharmaceuticals, Inc. | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $12 |
| Esperion Therapeutics, Inc. | 1 | $12 |
| Abbott | 1 | $12 |
| Ultragenyx Pharmaceutical Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,044 in reported general payments places this provider in the 95th percentile of 1,482 family medicine providers in Wisconsin.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 128 | $111,043 |
| JardianceEmpagliflozin | 93 | $88,001 |
| OzempicSemaglutide | 34 | $44,424 |
| XareltoRivaroxaban | 47 | $37,668 |
| JanuviaSitagliptin Phosphate | 34 | $33,922 |
| FarxigaDapagliflozin Propanediol | 30 | $27,395 |
| TrulicityDulaglutide | 21 | $25,953 |
| ZenpepLipase/Protease/Amylase | 22 | $23,262 |
| TradjentaLinagliptin | 24 | $22,207 |
| EntrestoSacubitril/Valsartan | 18 | $19,575 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $14,413 |
| EliquisApixaban | 15 | $12,861 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 52 | $11,601 |
| MyrbetriqMirabegron | 13 | $8,445 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $8,300 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $598 | $111,043128 claims |
| Boehringer IngelheimJardiance, Tradjenta | $492 | $110,208117 claims |
| Novo NordiskOzempic | $167 | $44,42434 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $846 | $40,64564 claims |
| Johnson & JohnsonXarelto | $1,296 | $37,66847 claims |
| MerckJanuvia | $273 | $33,92234 claims |
| GSKTrelegy Ellipta, Shingrix | $138 | $26,01464 claims |
| Lilly USA, LLCTrulicity | $13 | $25,95321 claims |
| Aimmune Therapeutics, Inc.Zenpep | $35 | $23,26222 claims |
| NovartisEntresto | $155 | $19,57518 claims |
| PfizerEliquis | $653 | $12,86115 claims |
| Astellas Pharma US IncMyrbetriq | $92 | $8,44513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,482 family medicine providers in Wisconsin.
Other family medicine in Milwaukee
- William PalinMilwaukee$693K
- Steven BondowMilwaukee$34K
- Suresh MisraMilwaukee$16K
- Ramneet BhathalMilwaukee$12K
- Roland WillockMilwaukee$7K
- Jennifer ParsleyElk Mound$1.4M
- Ryan AndrewsStevens Point$429K
- Tara DallDelafield$230K
- Mark JensonGreen Bay$204K
- James SamuelMount Pleasant$203K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.